Quarterly report pursuant to Section 13 or 15(d)

SCHEDULE OF REVENUES, OPERATING EXPENSES AND OPERATING INCOME (LOSS) BY REPORTABLE SEGMENT (Details)

v3.23.3
SCHEDULE OF REVENUES, OPERATING EXPENSES AND OPERATING INCOME (LOSS) BY REPORTABLE SEGMENT (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Segment Reporting Information [Line Items]        
Net revenue $ 29,280 $ 33,723 $ 88,643 $ 106,292
Direct operating costs 18,260 20,406 53,843 64,866
Selling and marketing 2,337 2,504 7,529 7,314
General and administrative 5,482 6,500 16,518 18,479
Research and development 1,260 1,168 3,523 3,251
Change in contingent consideration (1,660) (2,890)
Depreciation and amortization 3,903 2,810 10,282 8,686
Net loss on lease terminations and unoccupied lease charges 8 307 430 928
Total operating expenses 31,250 32,035 92,125 100,634
OPERATING (LOSS) INCOME (1,970) 1,688 (3,482) 5,658
Healthcare IT [Member]        
Segment Reporting Information [Line Items]        
Net revenue 25,592 29,964 78,531 96,146
Direct operating costs 15,369 17,582 46,003 56,878
Selling and marketing 2,329 2,496 7,503 7,293
General and administrative 2,719 3,231 8,466 10,213
Research and development 1,260 1,168 3,523 3,251
Change in contingent consideration   (1,660)   (2,890)
Depreciation and amortization 3,814 2,721 10,013 8,420
Net loss on lease terminations and unoccupied lease charges 8 307 430 928
Total operating expenses 25,499 25,845 75,938 84,093
OPERATING (LOSS) INCOME 93 4,119 2,593 12,053
Medical Practice Management [Member]        
Segment Reporting Information [Line Items]        
Net revenue 3,688 3,759 10,112 10,146
Direct operating costs 2,891 2,824 7,840 7,988
Selling and marketing 8 8 26 21
General and administrative 466 455 1,362 1,312
Research and development
Change in contingent consideration    
Depreciation and amortization 89 89 269 266
Net loss on lease terminations and unoccupied lease charges
Total operating expenses 3,454 3,376 9,497 9,587
OPERATING (LOSS) INCOME 234 383 615 559
Unallocated Corporate Expenses [Member]        
Segment Reporting Information [Line Items]        
Net revenue
Direct operating costs
Selling and marketing
General and administrative 2,297 2,814 6,690 6,954
Research and development
Change in contingent consideration    
Depreciation and amortization
Net loss on lease terminations and unoccupied lease charges
Total operating expenses 2,297 2,814 6,690 6,954
OPERATING (LOSS) INCOME $ (2,297) $ (2,814) $ (6,690) $ (6,954)